Cargando…
Durable Scar Size Reduction Due to Allogeneic Mesenchymal Stem Cell Therapy Regulates Whole‐Chamber Remodeling
BACKGROUND: Intramyocardial injection of mesenchymal stem cells (MSCs) in chronic ischemic cardiomyopathy is associated with reverse remodeling in experimental models and humans. Here, we tested the hypothesis that allogeneic MSC therapy drives ventricular remodeling by producing durable and progres...
Autores principales: | Williams, Adam R., Suncion, Viky Y., McCall, Frederic, Guerra, Danny, Mather, Jacques, Zambrano, Juan P., Heldman, Alan W., Hare, Joshua M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698774/ https://www.ncbi.nlm.nih.gov/pubmed/23686370 http://dx.doi.org/10.1161/JAHA.113.000140 |
Ejemplares similares
-
The Advancing Field of Cell‐Based Therapy: Insights and Lessons From Clinical Trials
por: Telukuntla, Kartik S., et al.
Publicado: (2013) -
Growth Hormone–Releasing Hormone Agonists Reduce Myocardial Infarct Scar in Swine With Subacute Ischemic Cardiomyopathy
por: Bagno, Luiza L., et al.
Publicado: (2015) -
Bond durability of contemporary adhesive systems to pulp chamber dentin
por: Ayar, Muhammet Kerim
Publicado: (2015) -
Durability and inflammogenic impact of carbon nanotubes compared with asbestos fibres
por: Osmond-McLeod, Megan J, et al.
Publicado: (2011) -
Whole-body cardiovascular MRI for the comparison of atherosclerotic burden and cardiac remodelling in healthy South Asian and European adults
por: Weir-McCall, Jonathan R, et al.
Publicado: (2016)